Hepatic haemangiomas: possible association with IL-17
Authors:
- 26 October 2011
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 65 (2) , 146-151
Abstract
Background Interleukin-17 (IL-17) has been cast as a major player in angiopoiesis of carcinoma, but its role in hepatic haemangioma is not entirely clear. Aim The aim of this study is to address the expression levels and the molecular mechanism underlying the role of IL-17 on hepatic haemangioma progression. Methods and Results 20 hepatic haemangioma patients and 15 healthy subjects were included in this study. IL-17 mRNA levels were examined by PCR-based methods and protein levels by western blot. We observed a significant increase in tissue IL-17 mRNA and protein levels in hepatic haemangioma compared to normal liver tissue. Matrix metalloproteinase protein levels were slightly elevated in haemangiomas compared to normal, and IL-6 and phospho-stat3 levels were markedly elevated. However, no differences in mRNA levels of angiogenesis-associated cytokines such as vascular endothelial growth factor were seen in hepatic haemangiomas compared to normal cases taken from donor livers at the time of organ harvest. IL-17 was localised to CD4-positive cells by flow cytometry and to stromal cells and endothelial cells by immunohistochemistry. Owing to the absence of an animal model of haemangioma, we examined the effects of IL-17 on angiogenesis-related functions of vascular endothelial cells in vitro. Notably, IL-17, when added to cell cultures of human umbilical cord-derived endothelial cells, had an effect on the secretion of IL-6 and p-stat3. Conclusions Based on these findings, we propose that IL-17 may mediate the angiogenesis in a IL-6-Stat3-dependent manner and play an important role in the pathophysiology of hepatic haemangioma.Keywords
This publication has 30 references indexed in Scilit:
- Expression of components of the renin–angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involutionJournal of Plastic, Reconstructive & Aesthetic Surgery, 2011
- Reappraisal of surgical indications and approach for liver hemangioma: single-center experience on 74 patientsThe American Journal of Surgery, 2011
- Magnetic resonance imaging of chronic bleeding into a giant hepatic hemangiomaEuropean Journal of Radiology Extra, 2011
- Propranolol for infantile haemangiomas: insights into the molecular mechanisms of actionBritish Journal of Dermatology, 2010
- Serum Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Children with Hemangiomas and Vascular Malformations—Preliminary ReportPediatric Dermatology, 2009
- Hypoxia-Induced Mediators of Stem/Progenitor Cell Trafficking Are Increased in Children With HemangiomaArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Management of Hepatic Hemangiomas: A 14-Year ExperienceJournal of Gastrointestinal Surgery, 2005
- Proliferative Hemangiomas: Analysis of Cytokine Gene Expression and AngiogenesisPlastic and Reconstructive Surgery, 1999
- Management and follow-up of 78 giant haemangiomas of the liverBritish Journal of Surgery, 1996
- Natural history of hepatic haemangiomas: clinical and ultrasound study.Gut, 1991